Parkinson's Disease
Why trials studying Parkinson's Disease stopped, in this sample of ClinicalTrials.gov.
18 stopped trials with a clear reason; 83% ended for non-scientific reasons.
| Reason | Trials | Share |
|---|---|---|
| funding business | 7 | 39% |
| slow accrual | 4 | 22% |
| logistics pi | 3 | 17% |
| futility | 2 | 11% |
| other | 1 | 6% |
| regulatory | 1 | 6% |
Trials
- Terazosin And Metabolic Engagement in Parkinson's Disease
NCT07288450 · WITHDRAWN · funding business
“Not Funded” - Attentional Performance in Parkinson Disease
NCT04428931 · WITHDRAWN · logistics pi
“The pandemic caused a delay in starting the study; PI is leaving.” - A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease
NCT04127695 · WITHDRAWN · funding business
“Strategic considerations” - Induction and Recognition of Emotions
NCT04353947 · WITHDRAWN · logistics pi
“COVID 19” - Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine
NCT04164758 · TERMINATED · funding business
“Study enrollment impacted by COVID-19 pandemic and Sponsor terminated for business reasons” - A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease
NCT03716570 · TERMINATED · futility
“Affiliated study NCT03318523 did not meet its primary outcome measure of change from baseline measured by Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and did not demonstrate efficacy on secondary outcome measures” - A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients
NCT02857244 · WITHDRAWN · regulatory
“Site did not obtain LIRB approval due to medication usage.” - Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
NCT02924194 · TERMINATED · slow accrual
“The study was halted prematurely due to lack of interested participants.” - Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
NCT02549573 · TERMINATED · slow accrual
“Subject enrollment is unsatisfactory” - Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia
NCT02589340 · TERMINATED · slow accrual
“Low enrollment” - Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease
NCT02401308 · TERMINATED · slow accrual
“Lack of subject enrollment.” - Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD
NCT02408562 · TERMINATED · funding business
“Issues with development and supply of infusion system for delivery of IMP. Prolonged approval process for the clinical study sNN0031-004.” - Perceptual Decision Making Under Conditions of Visual Uncertainty
NCT01845883 · WITHDRAWN · logistics pi
“Initiating PI has left the institution, and no participants have been enrolled for the interventional trial.” - Effect of Lower Extremity Ankle Foot Orthoses in Parkinson's Disease
NCT01798927 · TERMINATED · other
“Modifications are being made to protocol” - Molecular Analysis of Human Neural Stem Cells
NCT01329926 · WITHDRAWN · funding business
“insufficient funding” - Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off
NCT00601978 · WITHDRAWN · funding business
“Business decision brand strategy; no patients enrolled” - NET-PD LS-1 Creatine in Parkinson's Disease
NCT00449865 · TERMINATED · futility
“Futility” - Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease
NCT00208611 · TERMINATED · funding business
“Funding ended and enrollment not completed within a certain time period”
Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.